News | July 18, 2014

Civco Showcases Protura and Varian Interface at AAPM 2014

CIVCO Protura Robotic Patient Positioning System AAPM 2014 Radiation Therapy

July 18, 2014 — Civco Medical Solutions will demonstrate the Protura Robotic Patient Positioning System’s seamless interface with Varian’s Clinac iX and Trilogy medical linear accelerators via the Varian Motion Management Interface the American Association of Physicists in Medicine (AAPM) Annual Meeting in Austin, Texas, July 20-23, booth #607.

Civco’s Protura Robotic Patient Positioning System remotely repositions patients with robotic 6 degrees of freedom giving Varian Linac users the ability to ensure sub-millimeter positioning accuracy from outside the treatment room. Combined with Civco’s comprehensive motion management solutions, Protura is optimized to handle the rigors of a busy clinic while improving efficiency and throughput.

The Radiation Oncology Department at Università Cattolica Sacro Cuore (UCSC) Policlinico A. Gemelli, Rome, Italy, is the first facility to benefit from this seamless interface.

“The recent integration with Varian allows our facility to set up patients with essentially no time added to our treatment workflow-while improving quality assurance with no manual entry,” said Silvia Chiesa, M.D., Radiation Oncology Department at UCSC. “In addition to SRS, SRT and SBRT patient treatment, we also use the Protura system for our standard patient care, realizing the need to reduce rotational errors and improve setup accuracy for all IGRT treatment applications.”

Protura and Varian integration will be demonstrated in the Civco booth throughout the meeting. Civco’s team of motion management experts will demonstrate additional treatment solutions and how they simplify the clinician’s workday and improve workflow and efficiency between imaging and treatment. These and other solutions for head and neck, breast, lung, abdomen and prostate will be spotlighted in-booth and on interactive touchscreen displays.

  • Universal Couchtop Long Extension: The Universal Couchtop Long Extension (UCT LE) provides seamless imaging and treatment planning with dosimetrically matched couchtops that feature a large, junction-free & artifact-free treatment area. The unique profile of the UCT LE allows CIVCO’s SBRT Body Pro-Lok bridges to attach directly to the couchtop, enabling a seamlessly integrated SBRT immobilization platform.
  •  trUpoint ARCH SRS/SRT System: The newly released trUpoint ARCH improves the patient’s experience and quality of care during SRS/SRT treatments with a non-invasive accurate, repeatable and comfortable hold that allowed less than 1 mm of patient movement during intrafraction immobilization testing.
  • Body Pro-Lok SBRT Immobilization: Body Pro-Lok SBRT Immobilization allows for customized setups utilizing bridges that secure directly to the couchtop, thus eliminating the need for overlays and ensuring equivalent setups between computed tomography (CT) and treatment. The Body Pro-Lok System provides a simple, modular and reproducible foundation for any high-precision SBRT program, adapting to any department’s needs.
  • MRSeries Positioning Devices: MRSeries provides a new dimension in radiation therapy treatment planning. With patient positioning and fixation devices for every disease site, MRSeries enables accurate transfer from magnetic resonance imaging (MRI) imaging to treatment.
  • Fiducial Markers: Implantable fiducial markers provide a highly effective method of ensuring accurate target localization for tumors/organs that move in respect to external anatomy, as well as for the precise localization needed for stereotactic radiotherapy. CIVCO offers the largest selection of specially designed fiducial markers.
  • New Horizon Prone Breastboard: The New Horizon Prone Breastboard provides comfortable, reproducible patient positioning for prone breast treatments. Its modular design and variety of accessories allows for customized prone setups with an emphasis on patient comfort and safety.

 

For more information: www.CIVCO.com

 

Related Content

University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more...
Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res